Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain

Journal of Clinical Microbiology

Volumn 40, Issue 8, 2002, Pages 2959-2963

  García Rey, Cesar ^a   Aguilar, L ^a   Baquero, F ^a   Casal, J ^a   Martin J E ^a  

^a GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; DIRITHROMYCIN; ERYTHROMYCIN; MACROLIDE; ROXITHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CORRELATION COEFFICIENT; DRUG UTILIZATION; LINEAR REGRESSION ANALYSIS; NONHUMAN; PHARMACOEPIDEMIOLOGY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; SPAIN; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HOSPITALS; HUMANS; LINEAR MODELS; MICROBIAL SENSITIVITY TESTS; SPAIN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS PYOGENES;

EID: 0036701994     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.40.8.2959-2963.2002     Document Type: Article

References (35)

1. Bessen, D. E., M. W. Izzo, T. R. Fiorentino, R. M. Caringal, S. K. Hollingshead, and B. Beall. 1999. Genetic linkage of exotoxin alleles and emm gene markers for tissue tropism in group A streptococci. J. Infect. Dis. 179:627-636.
2. Bronzwaer, S. L., O. Cars, U. Buchholz, S. Mölstad, W. Goettsch, I. K. Veldhuijzen, J. L. Kool, M. JW. Sprenger, J. E. Degener, and the European Antimicrobial Resistance Surveillance System. 2002. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. 8:278-282.
3. Cars, O., S. Molstad, and A. Melander. 2001. Variation in antibiotic use in the European Union. Lancet 357:1851-1853.
4. Cizman, M., M. Pokorn, K. Seme, A. Orazem, and M. Paragi. 2001. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. J. Antimicrob. Chemother. 47:475-477.
5. Cornaglia, G., M. Ligozzi, A. Mazzariol, L. Masala, G. Lo Cascio, G. Orefici, R. Fontana, et al. 1998. Resistance of Streptococcus pyogenes to erythromycin and related antibiotics in Italy. Clin. Infect. Dis. 1:S87-S92.
6. de Neeling, A. J., B. P. Overbeek, A. M. Horrevorts, E. E. Ligtvoet, and W. G. Goettsch. 2001. Antibiotic use and resistance of Streptococcus pneumoniae in the Netherlands during the period 1994-1999. J. Antimicrob. Chemother. 48:441-444.
7. Enright, M. C., B. G. Spratt, A. Kalia, J. C. Cross, and D. E. Bessen. 2001. Multilocus sequence typing of Streptococcus pyogenes and the relationships between emm type and clone. Infect. Immun. 69:2416-2427.
8. Feil, E. J., E. C. Holmes, D. E. Bessen, M.-S. Chan, N. P. J. Day, M. C. Enright, R. Goldstein, D. W. Hood, A. Kalia, C. E. Moore, J. Zhou, and B. G. Spratt. 2001. Recombination within natural populations of pathogenic bacteria: Short-term empirical estimates and long-term phylogenetic consequences. Proc. Natl. Acad. Sci. USA 98:182-187.
9. García-Rey, C., L. Aguilar, F. Baquero, J. Casal, and R. Dal-Ré. 2002. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J. Clin. Microbiol. 40:159-164.
10. Gómez-Lus, R., J. J. Granizo, L. Aguilar, E. Bouza, A. Gutierrez, J. Garciade-Lomas, and the Spanish Surveillance Group for Respiratory Pathogens. 1999. Is there an ecological relationship between rates of antibiotic resistance of species of the genus Streptococcus? J. Clin. Microbiol. 37:3384-3386.
11. Granizo, J. J., L. Aguilar, J. Casal, R. Dal-Ré, and F. Baquero. 2000. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J. Antimicrob. Chemother. 46:959-964.
12. Granizo, J. J., L. Aguilar, J. Casal, C. García-Rey, R. Dal-Ré, and F. Baquero. 2000. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J. Antimicrob. Chemother. 46:767-773.
13. Hsueh, P. R., H. M. Chen, A. H. Huang, and J. J. Wu. 1995. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob. Agents Chemother. 39:2239-2242.
14. Huovinen, P., H. Seppälä, J. Kataja, T. Klaukka, and the Finnish Study Group of Antimicrobial Resïstance. 1997. The relationship between erythromycin consumption and resistance in Finland. Ciba Found. Symp. 207:36-46.
15. Kalia, A., B. G. Spratt, M. C. Enright, and D. E. Bessen. 2002. Influence of recombination and niche separation on the population genetic structure of the pathogen Streptococcus pyogenes. Infect. Immun. 70:1971-1983.
16. Kaplan, E. L. 1991. The resurgence of group A streptococcal infections and their sequelae. Eur. J. Clin. Microbiol. Infect. Dis. 10:55-57.
17. Leibovici, L., R. Berger, T. Gruenewald, J. Yahav, Y. Yehezkelli, G. Milo, M. Paul, Z. Samra, and S. D. Pitlik. 2001. Departmental consumption of antibiotic drugs and subsequent resistance: A quantitative link. J. Antimicrob. Chemother. 48:535-540.
18. Levin, B. R. 2001. Minimizing potential resistance: A population dynamics view. Clin. Infect. Dis. 33(Suppl. 3):S161-S169.
19. Lopez-Lozano, J. M., D. L. Monnet, A. Yague, A. Burgos, A. Gonzalo, P. Campillos, and J. M. Saez. 2000. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: A time series analysis. Int. J. Antimicrob. Agents 14:21-31.
20. Lowbury, E. J. L., and L. Hurst. 1959. The sensitivity of staphylococci and other wound bacteria to erythromycin, oleandomycin and spiramycin. J. Clin. Pathol. 12:163-164.
21. Maruyama, S., H. Yoshioka, K. Fujita, M. Takimoto, and Y. Satake. 1979. Sensitivity of group A streptococci to antibiotics. Prevalence of resistance to erythromycin in Japan. Am. J. Dis. Child. 133:151-154.
22. Melander, E., K. Ekdahl, G. Jonsson, and S. Molstad. 2000. Frequency of penicillin-resistant pneumococci in children is correlated to community utilization of antibiotics. Pediatr. Infect. Dis. J. 19:1172-1177.
23. National Committee for Clinical Laboratory Standards. 1997. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 4th Ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Wayne, Pa.
24. Orden, B., E. Përez-Trallero, M. Montes, and R. Martínez. 1998. Erythromycin resistance of Streptococcus pyogenes in Madrid. Pediatr. Infect. Dis. J. 17:470-473.
25. Pérez-Trallero, E., C. Fernändez-Mazarrasa, C. Garcïa-Rey, E. Bouza, L. Aguilar, J. Garcia-de-Lomas, F. Baquero, and the Spanish Surveillance Group for Respiratory Pathogens. 2001. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: Results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob. Agents Chemother. 45:3334-3340.
26. Përez-Trallero, E., J. M. Marimön, M. Montes, B. Orden, and M. de Pablos. 1999. Clonal differences among erythromycin-resistant Streptococcus pyogenes in Spain. Emerg. Infect. Dis. 5:235-240.
27. Peter, G. 1992. Streptococcal pharyngitis: Current therapy and criteria for evaluation of new agents. Clin. Infect. Dis. 2:S218-223, S231-232.
28. Reinert, R. R., A. Al-Lahham, M. Lemperle, C. Tenholte, C. Briefs, S. Haupts, H. H. Gerards, and R. Lutticken. 2001. Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany. J. Antimicrob. Chemother. 49:61-68.
29. Seppala, H., A. Nissinen, H. Jarvinen, S. Huovinen, T. Henriksson, E. Herva, S. E. Holm, M. Jahkola, M. L. Katila, T. Klaukka, et al. 1992. Resistance to erythromycin in group A streptococci. N. Engl. J. Med. 326:292-297.
30. Seppala, H., T. Klaukka, K. Vuopio-Varkila, A. Muotiala, H. Helenius, K. Lager, P. Huovinen, et al. 1997. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N. Engl. J. Med. 337:441-446.
31. Stingemore, N., G. R. Francis, M. Toohey, and D. B. McGechie. 1989. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantie, Western Australia. Med. J. Aust. 150:626-627, 630-631.
32. Syrogiannopoulos, G. A., I. N. Grivea, F. Fitoussi, C. Doit, G. D. Katopodis, E. Bingen, and N. G. Beratis. 2001. High prevalence of erythromycin resistance of Streptococcus pyogenes in Greek children. Pediatr. Infect. Dis. J. 20:863-868.
33. Weber, P., J. Filipecki, E. Bingen, F. Fitoussi, G. Goldfarb, J. P. Chauvin, C. Reitz, and H. Portier. 2001. Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France. J. Antimicrob. Chemother. 48:291-294.
34. Weiss, K., J. de Azavedo, C. Restieri, L. A. Galarneau, M. Gourdeau, P. Harvey, J. F. Paradis, K. Salim, and D. E. Low. 2001. Phenotypic and genotypic characterization of macrolide-resistant group A Streptococcus strains in the province of Quebec, Canada. J. Antimicrob. Chemother. 47:345-348.
35. World Health Organization Collaborating Center for Drug Statistic Methodology. 2002. ATC index with DDDs. World Health Organization Collaborating Center for Drug Statistic Methodology, Oslo, Norway.